Long-Term Treatment With Rosiglitazone and Metformin Reduces the Extent of, but Does Not Prevent, Is...
Long-Term Treatment With Rosiglitazone and Metformin Reduces the Extent of, but Does Not Prevent, Islet Amyloid Deposition in Mice Expressing the Gene for Human Islet Amyloid Polypeptide
About this item
Full title
Author / Creator
Publisher
Alexandria, VA: American Diabetes Association
Journal title
Language
English
Formats
Publication information
Publisher
Alexandria, VA: American Diabetes Association
Subjects
More information
Scope and Contents
Contents
Long-Term Treatment With Rosiglitazone and Metformin Reduces the Extent of, but Does Not Prevent, Islet Amyloid Deposition
in Mice Expressing the Gene for Human Islet Amyloid Polypeptide
Rebecca L. Hull 1 ,
Zhen-Ping Shen 1 ,
Melissah R. Watts 1 ,
Keiichi Kodama 1 ,
Darcy B. Carr 2 ,
Kristina M. Utzschneider 1 ,
Sakeneh Zrai...
Alternative Titles
Full title
Long-Term Treatment With Rosiglitazone and Metformin Reduces the Extent of, but Does Not Prevent, Islet Amyloid Deposition in Mice Expressing the Gene for Human Islet Amyloid Polypeptide
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_67985556
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67985556
Other Identifiers
ISSN
0012-1797
E-ISSN
1939-327X
DOI
10.2337/diabetes.54.7.2235
